Patient characteristics
| Group | n | Female /male | Age (mean) | GPT(U/l; mean) | Viral load (mean) | HCV GT1 | Anti-HBe ± n.d. | ||
| arHBV | 19 | 6/13 | 38.4 | 2,567 | 19.6 × 106 cop/ml | - | 8 | 6 | 5 |
| cHBV | 24 | 7/17 | 44.6 | 59.5 | 18.3 × 103 cop/ml | - | 13 | 5 | 6 |
| aHCV | 14 | 6/8 | 53.5 | 984 | 6.9 × 106 IU/ml | 9 | - | ||
| cHCV | 7 | 3/4 | 44.8 | 81.9 | 0.8 × 106 IU/ml | n.d. | - | ||
| rHBV | 5 | 0/5 | 47.4 | normal | negative | - | - | ||
| rHCV | 7 | 3/4 | 53.3 | normal | negative | n.d. | - | ||
| aEBV | 3 | 2/1 | 44.3 | n.d. | negative | - | - | ||
| healthy | 9 | 8/1 | 39.1 | normal | negative | - | - | ||
| Group | n | Female /male | Age (mean) | GPT(U/l; mean) | Viral load (mean) | HCV GT1 | Anti-HBe ± n.d. | ||
| arHBV | 19 | 6/13 | 38.4 | 2,567 | 19.6 × 106 cop/ml | - | 8 | 6 | 5 |
| cHBV | 24 | 7/17 | 44.6 | 59.5 | 18.3 × 103 cop/ml | - | 13 | 5 | 6 |
| aHCV | 14 | 6/8 | 53.5 | 984 | 6.9 × 106 IU/ml | 9 | - | ||
| cHCV | 7 | 3/4 | 44.8 | 81.9 | 0.8 × 106 IU/ml | n.d. | - | ||
| rHBV | 5 | 0/5 | 47.4 | normal | negative | - | - | ||
| rHCV | 7 | 3/4 | 53.3 | normal | negative | n.d. | - | ||
| aEBV | 3 | 2/1 | 44.3 | n.d. | negative | - | - | ||
| healthy | 9 | 8/1 | 39.1 | normal | negative | - | - | ||